Contact information
Rosie Bradley
BSc, MSc
Medical Statistician
Rosie is a Medical Statistician in the Clinical Trial Service Unit (CTSU). Prior to joining in 2012, she studied Applied Statistics at the University of Plymouth (BSc) and Biometry at the University of Reading (MSc). She is currently involved in randomised trials in neurodegenerative diseases and is working on meta-analyses of breast cancer trials in EBCTCG.
Recent publications
-
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Journal article
Howard R. et al, (2018), Health Technol Assess, 22, 1 - 62
-
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Journal article
Howard R. et al, (2018), Lancet Psychiatry, 5, 553 - 563
-
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39
-
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1353 - 1361
-
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1341 - 1352